ASBPW (STOCKS)
Aspire Biopharma Holdings, Inc. Warrant
—
Change: —
Prev close: —
Company Information
- Exchange
- XNAS
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $6.20K |
| Benefits Costs and Expenses | $24.49M |
| Costs And Expenses | $24.49M |
| Nonoperating Income/Loss | -$5.13M |
| Operating Expenses | $19.35M |
| Research and Development | $923.91K |
| Other Operating Expenses | $18.43M |
| Operating Income/Loss | -$19.35M |
| Income/Loss From Continuing Operations After Tax | -$24.48M |
| Income/Loss From Continuing Operations Before Tax | -$24.48M |
| Net Income/Loss | -$24.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$24.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$24.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Earnings Per Share | -$16.38 |
| Basic Average Shares | 1,494,956 |
| Diluted Average Shares | 1,494,956 |
| Assets | $1.31M |
| Current Assets | $1.31M |
| Noncurrent Assets | $0.00 |
| Liabilities | $7.69M |
| Current Liabilities | $7.59M |
| Accounts Payable | $1.01M |
| Other Current Liabilities | $6.58M |
| Noncurrent Liabilities | $95.66K |
| Equity | -$6.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$6.38M |
| Liabilities And Equity | $1.31M |
| Net Cash Flow From Operating Activities | -$4.92M |
| Net Cash Flow From Operating Activities, Continuing | -$4.92M |
| Net Cash Flow From Investing Activities | -$1.00M |
| Net Cash Flow From Investing Activities, Continuing | -$1.00M |
| Net Cash Flow From Financing Activities | $5.92M |
| Net Cash Flow From Financing Activities, Continuing | $5.92M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$24.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$24.48M |
| Other Comprehensive Income/Loss | $0.00 |